NDT Advance Access originally published online on January 31, 2006
Nephrology Dialysis Transplantation 2006 21(6):1564-1569; doi:10.1093/ndt/gfk090
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Original Articles: Clinical Nephrology
Therapeutic approach in patients with dysnatraemias
Department of Internal Medicine, Medical School, University of Ioannina, 45110 Ioannina, Greece
Correspondence and offprint requests to: Moses Elisaf, MD, FRSH, FASA, Professor of Medicine, Department of Internal Medicine, University of Ioannina, 45110 Ioannina. Email: egepi{at}cc.uoi.gr
Background. Rapid correction of dysnatraemias is frequently associated with increased morbidity and mortality. Therefore, it is important to estimate the proper volume and type of infusate required to change the serum sodium concentration predictably. The aim of this study is to evaluate the utility or/and the accuracy of the Adrogue–Madias formula in managing patients with hyponatraemia and hypernatraemia.
Methods. Among the 317 patients who either on admission to our internal medicine clinic or during their hospitalization were found to have hyponatraemia or hypernatraemia, we studied 189 patients (59.6%) in whom the administration of intravenous solutions was required for the correction of dysnatraemias.
Results. Twelve hours after starting the administration of intravenous solutions the anticipated as well as the achieved serum sodium concentration were as follows: in volume depleted patients 130.2±4.1 vs 131.3±5.2 meq/l (n = 45; P = NS), in syndrome of inappropriate antidiuretic hormone secretion (SIADH) patients 127.4±5.7 vs 128.9±5.9 meq/l (n = 10; P = NS), in patients with diuretic-induced hyponatraemia 123.8±6 vs 125.5±5.6 meq/l (n = 29; P = NS), in patients with primary polydipsia 122.5±0.7 vs 129±1.4 meq/l (n = 2; P = 0.02), while in patients with hypernatraemia 153.6±7.5 vs 156.5±8.9 meq/l (n = 92; P = 0.021). Furthermore, 24 h from the initiation of the therapeutic intervention the expected and the achieved serum sodium concentrations were 130±4 vs 135.6±3.3 meq/l (n = 15; P = 0.002) in patients with volume depletion, 128.1±4.8 vs 130±4.5 meq/l (n = 15; P = NS) in patients with diuretic-induced hyponatraemia and 151.5±6.4 vs 153.3±8.3 meq/l (n = 67; P = NS) in patients with hypernatraemia.
Conclusions. The formula that has been proposed by Adrogue and Madias predicted with relative accuracy the changes in serum sodium concentration in almost all patients. Thus, it should be considered as a very useful tool for the management of dysnatraemias. However, special attention should be paid when this equation is used in patients with hyponatraemia due to extracellular volume depletion after euvolaemia's restoration and primary polydipsia in order to avoid rapid correction of hyponatraemia.
Keywords: adrogue–madias formula; hypernatraemia; hyponatraemia
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. J. Hoorn, N. van der Lubbe, and R. Zietse SIADH and hyponatraemia: why does it matter? NDT Plus, November 1, 2009; 2(suppl_3): iii5 - iii11. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zietse, N. van der Lubbe, and E. J. Hoorn Current and future treatment options in SIADH NDT Plus, November 1, 2009; 2(suppl_3): iii12 - iii19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Liamis, H. J. Milionis, and M. Elisaf A review of drug-induced hypernatraemia NDT Plus, October 1, 2009; 2(5): 339 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Lindner, C. Schwarz, N. Kneidinger, L. Kramer, R. Oberbauer, and W. Druml Can we really predict the change in serum sodium levels? An analysis of currently proposed formulae in hypernatraemic patients Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3501 - 3508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Liamis, V. Tsimihodimos, M. Doumas, A. Spyrou, E. Bairaktari, and M. Elisaf Clinical and laboratory characteristics of hypernatraemia in an internal medicine clinic Nephrol. Dial. Transplant., January 1, 2008; 23(1): 136 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. Mohmand, D. Issa, Z. Ahmad, J. D. Cappuccio, R. W. Kouides, and R. H. Sterns Hypertonic Saline for Hyponatremia: Risk of Inadvertent Overcorrection Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1110 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Berl The Adrogue-Madias Formula Revisited Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1098 - 1099. [Full Text] [PDF]
|
|
|
|
 |
|
 M Biswas and J S Davies Hyponatraemia in clinical practice Postgrad. Med. J., June 1, 2007; 83(980): 373 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Ellison and T. Berl The Syndrome of Inappropriate Antidiuresis N. Engl. J. Med., May 17, 2007; 356(20): 2064 - 2072. [Full Text] [PDF]
|
|